Atorvastatin Tablets
10 · 20 · 40 · 80mg
Developed to support cholesterol management to alleviate cardiovascular risk.
Cholesterol Management Medications
Cholesterol management medicines help reduce harmful lipid levels and lower cardiovascular risk when lifestyle changes alone are not enough or when risk is already high. This category is most useful when you compare LDL cholesterol, triglycerides, and overall heart-risk goals separately.
Bempedoic Acid Tablets
180mg
Designed to manage blood cholesterol levels and to support to alleviate dyslipidaemia, indicated for patients with insufficient control on lipid-lowering therapies.
Crestor
5 · 10 · 20mg
intended to target elevated cholesterol levels within the blood to manage cardiovascular risk.
Ezetimibe Tablets
10mg
designed to mitigate high cholesterol levels indicated to support cardiovascular function.
Fenofibrate Tablets
160 · 200mg
Utilized to manage hypercholesterolaemia, intended to support lipid level reduction.
Gemfibrozil Tablets
300mg
Indicated to target high triglycerides, utilized to manage lipid profiles.
Lipitor
10 · 20 · 40mg
indicated to manage high cholesterol levels and to alleviate the risk of future cardiovascular complications through HMG-CoA reductase inhibition.
Livalo
1 · 2 · 4mg
Product indicated to manage hypercholesterolaemia and designed to support cardiovascular health by reducing cholesterol production.
Lopid
300mg
Indicated to support the reduction of triglycerides, developed to manage dyslipidaemia effectively.
Questran
4g
Indicated for hypercholesterolaemia, utilized to target bile acids in the gut to alleviate elevated blood cholesterol and support lipid management.
Roszet
10/10mg
Developed for hypercholesterolaemia, intended to target cholesterol synthesis and absorption to alleviate lipid levels and support cardiovascular health.
Simvastatin Tablets
5 · 10 · 20 · 40mg
indicated to lower lipid levels to manage cardiovascular disease risks.
Zocor
5 · 10 · 20 · 40mg
Indicated to support the reduction of cholesterol levels, formulated to mitigate cardiovascular risk by inhibiting a key enzyme in cholesterol synthesis.
What this category helps you sort out
Cholesterol is not one number. LDL, HDL, triglycerides, age, blood pressure, diabetes, smoking, kidney disease, and previous heart or stroke events all affect why a medicine may be chosen.
Some medicines reduce cholesterol made in the liver, some reduce absorption in the gut, and others focus more on triglycerides. The right choice is usually guided by blood tests and risk calculation rather than symptoms.
How to compare options
- Know the lipid target: LDL reduction, triglyceride reduction, or secondary prevention after a cardiovascular event.
- Check whether the medicine needs liver tests, muscle-symptom monitoring, or dose timing.
- Review interactions with antibiotics, antifungals, HIV medicines, ciclosporin, grapefruit, and alcohol where relevant.
- Do not stop cholesterol medicine because you feel well; high cholesterol is often silent.
Common medication groups
Statins
Statins reduce cholesterol production in the liver and are widely used to lower LDL cholesterol and cardiovascular risk. Muscle symptoms, liver tests, and interactions are common comparison points.
Absorption inhibitors and bile acid sequestrants
These medicines reduce how much cholesterol is absorbed or recycled through the gut. They may be added when LDL targets are not reached or when statins are unsuitable.
Fibrates and triglyceride-focused medicines
Fibrates are usually considered when triglycerides are a major concern. They have their own kidney, liver, and muscle-safety considerations, especially with other lipid medicines.
Safety notes for this category
Report unexplained muscle pain, weakness, dark urine, jaundice, or severe abdominal pain. Pregnancy and breastfeeding usually require a specific medication review.
Because lipid treatment is risk-based, dose changes should follow blood tests and clinical review rather than a single comparison page.
Important Safety Information
Cholesterol medicines differ in lipid target, interaction profile, and monitoring needs. This page is educational and does not replace cardiovascular-risk assessment, blood-test review, or product labeling.